Abstract Background Cardiac masses (CM) are an extremely heterogeneous clinical scenario, including benign and malignant neoformations. After a first echocardiographic assessment, Computed Tomography (CCT) together with Magnetic Resonance (CMR) 18-Fluorodeoxyglucose Positron Emission (18-FDG-PET) represent second-line third-line imaging techniques to determine the nature of mass. However, data ...